Provider review
Midi Health review
It can prescribe compounded GLP-1s too, not just brand-name
A menopause practice that takes insurance in all 50 states: $250 for the first visit, $150 after, with the drug billable to your plan. It can prescribe compounded GLP-1s as well as brand — but its clinicians cannot treat Medicaid patients at all, even self-pay.
Straight talk: how we earn — some, not all, of these are affiliate links; start a program through one and we may earn a commission at no extra cost to you. Straight about the rest, too: the write-ups say what each provider is actually worth, and a commission does not change a word of them. Full disclosure here.
On this page
The verdict
Midi Health is the most transparent provider here — real, specific self-pay prices, an explicit insurance-exclusion policy stated in its own words, and a GLP-1 offering that includes compounded options rather than branded-only — though it's built around menopause care first, with GLP-1 as an adjunct, not a standalone product.
Midi Health is not ranked on any of our rankings. This is a standalone read of what the company publishes about itself — the providers we do rank in this category are on our semaglutide provider ranking. Nothing on this page is a performance claim — see the evidence review for what these compounds do and do not do.
Who it is for, and who it is not
A good fit if
- You're seeking menopause or perimenopause care and want GLP-1 access folded into that relationship
- You have commercial insurance and want the option to bill GLP-1 medication through it
- You want transparent, published self-pay visit fees rather than a 'contact us' gate
Look elsewhere if
- You're on Medicaid or Medi-Cal — explicitly excluded, even as a self-pay patient
- You want GLP-1 prescribing guaranteed at intake rather than at clinician discretion within a broader plan
- You're a man, or a younger woman whose main goal is weight loss rather than menopause care
What it actually costs
What they advertise
$250 for the initial visit, $150 for continued-care visits; GLP-1 medication can also be billed through commercial insurance (copay plus deductible).
What you actually pay, month to month
$150/month in ongoing visit fees is confirmed; medication cost depends on your insurance copay and deductible or a compounded self-pay rate, neither published as a flat figure.
The commitment trap
The $250 figure is a one-time initial visit, not a recurring charge — the $150 is the real ongoing rate for continued-care visits, not a discount off the $250.
Checked live on Midi Health's own site at https://www.joinmidi.com/pricing-insurance in August 2026. Prices change without notice — confirm before you buy. Work out what a vial actually gives you with our peptide dose calculator.
What is included
The cheapest headline number in this category is often the one with the least attached to it. Here is what Midi Health bundles in, and what it does not.
Clinician consult
Initial visit ($250) and continued-care visits ($150) with Midi's clinical network; no individual clinicians named.
Bloodwork / labs
Not published.
Follow-ups and dose changes
Continued-care visits priced separately at $150.
Human support
Nothing published beyond visit-based care.
Injection supplies
Not published.
Shipping
Not published.
Pharmacy, labs and oversight
The pharmacy
Not individually named — both brand-name and compounded GLP-1 options are described as available at clinician discretion.
Oversight
Continued-care visits priced separately at $150.
Compounded peptides are not FDA-approved products, and a 503A pharmacy compounds for a named patient while a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not. Our guide to verifying a certificate of analysis covers what to ask for.
Where you can get it
All 50 states; Medicaid and Medi-Cal patients explicitly excluded, even as self-pay.
The honest cons
The part they would rather you skipped
Midi Health's own Terms state plainly that Medicaid and Medi-Cal patients cannot be treated even as self-pay — a real exclusion worth knowing if you're on either program.
- Medicaid and Medi-Cal patients explicitly excluded, even as self-pay
- GLP-1 prescribing is at clinician discretion within a menopause plan, not guaranteed at intake
- Menopause-focused positioning isn't the right fit for men or younger women focused purely on weight loss
- No individual clinicians named on marketing pages
None of this is unique to Midi Health — the whole category shares it. What we hold against a provider is the part it hides, and the ways vendors hide things are cataloged in our vendor red-flags guide.
How it compares
The providers we rank on our semaglutide provider ranking, in the order that ranking ranks them. Midi Health is not among them: it is reviewed here, not ranked there, and we would rather show you the comparison than pretend the two are the same thing.
- COCollectiveThe cheapest medication price here, on a membership the headline omits
- CoreAge RxOne price that does not move when your dose does
- BHBodybuilding Health+The deep peptide catalog is gone; the GLP-1 pricing got better
- RxSpan MDOral tablet only, at a real $179 monthly rate
- Enhance MDWrites a flat-price-at-every-dose policy down — and charges near the top for it
- Found HealthInsurance-integrated, unlike every cash-only compounder here — but $99 needs a prepay
- Direct MedsThe plainest price mechanics on either ranking, from a company with an FDA warning letter
- Synergy RxPublishes a starting number, and nothing about what it commits you to
13 more providers rank on our semaglutide provider ranking — see the full ranking. Every provider we review →
Read this before you buy
A provider comparison is half the decision. The other half is whether the compound does anything for you at all — and whether it is allowed where you compete. Growth-hormone secretagogues are banned in tested sport, year-round, and a prescription does not change that.
Facts on this page reflect Midi Health's own public disclosures when we last checked them, in August 2026. Prices and terms change without notice — confirm on Midi Health's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved, and growth-hormone secretagogues are banned in tested sport year-round. See our disclosure and editorial policy.